Beat the target, missed the growth story
Repco delivered Q2 disbursement bang on target (₹1,205 Cr), but AUM growth came in 4–5 percentage points short of guidance. Profit is steady, but the margin story is tightening.
₹1,205 Cr
vs ₹1,200–1,250 Cr target (HIT)
9.2%
vs 13–14% guidance (MISS −4-5pp)
₹477.4 Cr
+8.2% YoY · modest growth
₹398 Cr
−₹79 Cr YoY (on track <2% by Mar)
On the surface: Q2 looks solid. Repco hit its quarterly disbursement target right in the middle (₹1,205 Cr), asset quality is improving (gross NPA down ₹79 Cr year-on-year), and profit guidance for FY27 (₹480–490 Cr) remains on track. But beneath the headline, the tension is real. AUM growth came in at 9.2% — nearly a full year of growth short of the 13–14% prior guidance. That's a material miss for a housing finance company betting on volume. Add in rising cost of funds post-RBI hikes (8.35% now, expecting +10–15 bps more), and the margin story is tightening. The question on the call became not 'Are you hitting your numbers?' but 'Can you hit them faster than your margins compress?'
What changed on this call
Q3 & Q4 targets now explicit: ₹1,300–1,350 Cr (Q3) and ₹1,650–1,700 Cr (Q4). These are ambitious — Q4 needs 40%+ growth from Sept levels.
AUM guidance implicitly missed: No formal cut, but 9.2% growth vs. prior 13–14% signals the prior estimate was wrong.
Cost/margin pressure materialized: RBI rate hikes have raised cost of funds and tightened spreads faster than management flagged in prior calls. Spread narrowing to 3.25–3.3% (from 3.4%) is now explicit.
NPA and profitability track intact: Gross NPA headed below 2% by March (currently 2.4%), and ₹480–490 Cr profit guidance for FY27 still holds.
Management transition (Vaidyanathan → Kannan): New CRO took charge; management downplayed impact as routine. Market did not push back hard.
The bull-bear ledger
Q2 disbursement target hit; execution in focus area solid
Gross NPA improving sharply (−₹79 Cr YoY); on track to sub-2% by March
New disbursement channels (DST, DSA, LLMS) ramping; management confident on Q3–Q4 pace
FY27 profit guidance (₹480–490 Cr) maintained; H1 ₹230 Cr on track for 50% of target
Asset quality best in 16 years; majority book urban/Tier-1/2 cities; no regional stress
AUM growth 4–5 percentage points below guidance; material execution gap
Margin compression building: spread 3.4% targeting 3.25–3.3% (−10–15 bps)
Cost of funds rising post-RBI hikes (+10–15 bps expected); erodes profitability unless passed to borrowers
Q1 disbursement missed (₹843 Cr vs ~₹1,000 Cr); Q3–Q4 targets are aggressive and depend on new channels delivering
Smaller competitor in consolidating HFC sector (HDFC, ICICI dominant); limited pricing power vs. larger players
Risks ranked by how much they should concern a holder
Cost of funds pressure & margin squeeze — Post-RBI hikes, cost of funds now 8.35% with +10–15 bps more expected; spread narrowing from 3.4% to 3.25–3.3%.
HighProfitability is leveraged to spread. If cost of funds rises faster than Repco can pass it to borrowers, NIM (currently 5.44%) erodes, reducing profit upside. The lag effect is 1 quarter — Q3–Q4 will show the real hit.
AUM growth shortfall — 9.2% YoY vs. 13–14% guidance is a −4–5pp miss; suggests demand, regulatory, or internal execution constraints.
HighAUM growth is the volume lever. If the company cannot grow disbursements faster than margins compress, the top-line growth story stalls. This is the core tension of the quarter.
Q3–Q4 execution risk — Targets of ₹1,300–1,350 Cr (Q3) and ₹1,650–1,700 Cr (Q4) are ambitious (40%+ growth from Sept); June quarter missed target.
MediumFY27 profit guidance (₹480–490 Cr) depends on hitting these targets. Miss in either quarter threatens full-year number and calls into question management credibility on disbursement ramp.
New channel (DST/DSA) execution — Management betting on DST hiring, DSA network, and LLMS tech to drive Q3–Q4 volume, but these are new and unproven at scale.
MediumIf channels don't scale or cannibalize existing business, disbursement targets will miss. Analysts pressed on this; management held firm but provided limited proof.
Competitive positioning — Smaller mid-sized HFC in a consolidating sector; HDFC/ICICI have scale, cost of funds, pricing power advantage.
MediumIf rate cycle tightens further, larger competitors can cut spreads, squeeze smaller players' margins faster. Repco's 2.4% gross NPA is healthy now, but quality of new book matters as pricing power erodes.
NPA deterioration (if macro worsens) — Currently 2.4%, target <2% by March; majority book urban but asset quality is cyclical.
LowImproving now (−₹79 Cr YoY), but if lending quality slips or new disbursement mix deteriorates, NPA could rise. Management claims confidence; portfolio is urban/Tier-1/2, mitigating risk. Still, watch this quarterly.
How the street is positioned
Price & technical: Repco closed Q2 at ₹386.75, trading above its 20-day (₹324.83), 50-day (₹339.63), and 200-day (₹376.25) moving averages. RSI sits at 74.7 — overbought territory — signaling recent buying has been brisk. From the 52-week low of ₹294.05, the stock is up 31.5%; from the prior all-time high of ₹924, it's down 58.1%, suggesting structural questions about the franchise persist despite the recent rally.
Ownership flows: FII holdings have slipped to 12.35% (−1.02 percentage points QoQ), while DII holdings rose to 26.08% (+1.8pp). Promoter stake is steady at 37.13%. The divergence is telling: domestic institutions and retail are adding; foreign investors are trimming. This aligns with the mixed fundamental story — domestic players may see value in the NPA improvement and branch expansion; foreigners may be wary of the margin squeeze and growth shortfall.
The interpretation: The stock has recovered sharply from its lows but remains half its prior peak, and overbought technicals suggest the recent rally has run ahead of fundamentals. The FII outflow during a strong Q2 beat hints that foreign money does not believe the growth story can overcome margin compression. Domestic buying may be opportunistic value-chasing on the NPA improvement narrative, but it lacks conviction if Q3–Q4 disbursement targets miss.
1 · Q3 disbursement and AUM growth delivery (Dec 2026 call)
The acid test. Management has guided ₹1,300–1,350 Cr for Q3. This is 8% above Q2 and requires DST/DSA channels to be live and producing. If Q3 comes in below ₹1,250 Cr, Q4 targets (₹1,650–1,700 Cr) will be unrealistic, and the full-year ₹480–490 Cr profit guidance is at risk. Also watch AUM growth — if it remains stuck at 9%, the growth narrative has broken.
2 · Spread and NIM evolution (Q3 FY27 earnings)
Management is targeting 3.25–3.3% spread (from current 3.4%). This compression is critical to track. If cost of funds rises faster than pricing discipline allows spread to hold at the guidance range, NIM will fall faster than expected, and profitability guidance could face pressure in Q4.
3 · Gross NPA progression (Q3 FY27 earnings)
Target is below 2% by March 2027. Currently at 2.4% and improving (−₹79 Cr YoY). If the trend reverses or stalls, it signals lending quality deterioration or new book risk. This is a confidence check on the disbursement ramp quality.
4 · FII/DII flow during Q3–Q4 earnings cycle
Watch ownership shifts. If FII continues to trim while DII adds, it suggests foreign investors lack conviction on the growth × margin story. A reversal — FII adding back — would signal the market believes the new channel ramp will offset cost pressure.
Repco delivered a solid Q2 — target met, asset quality improving, and the FY27 profit guidance intact. But the quarter exposed a real tension: the company is fighting to grow while margins compress. Single-digit revenue and profit growth is not the story of a high-growth franchise. The next 2–3 quarters will decide whether the new disbursement channels (DST, DSA) can ramp volume faster than cost of funds erodes profit. Until then, this is a hold — steady execution in a tightening environment, not a catalyst for re-rating.
The number to track from here: AUM growth in Q3 (Dec 2026 call). If Repco can return to double-digit AUM growth while holding spreads at 3.25–3.3%, the bear case fades and the bull case holds. If AUM growth remains in single digits despite the new channels, the growth shortfall is structural, and downside risk emerges.
Disbursement on track, AUM growth softens 9% vs 14% guidance
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit Q2 disbursement target; missed Q1 (843 Cr vs ~1000 Cr target). AUM growth miss (9.2% vs 13-14%) material.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q2 disbursement target met (₹1,205 Cr), NPA improving, but AUM growth significantly missed guidance (9.2% vs 13-14%). Margin compression from rising cost of funds (8.35%, expecting +10-15 bps) and spread pressure (3.4% → 3.25-3.3%) offset modest topline growth. Asset quality improving justifies the hold, but growth miss warrants caution.
₹477.4 Cr
Revenue · +8.2% YoY₹119.1 Cr
Reported PAT · +8.6% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Q2 disbursement target ₹1,200-1,250 Cr met
METDelivered ₹1,205 Cr in Sept quarter
AUM growth 13-14% FY27 guidance
OVERSTATEDDelivered 9-9.2% YoY growth (Sept ₹16,425 Cr)
NPA reduction ₹40 Cr on track
METReduced ₹427 Cr (June) to ₹398 Cr (Sept), ~₹29 Cr H1; on track
Cost of funds stable 8.3%
OVERSTATED8.35% at Sept (slight increase), post-RBI hikes expected +10-15 bps
Q1 June target ~₹1,000 Cr disbursement
OVERSTATEDDelivered ₹843 Cr (84% of target)
Earnings quality
What changed since the last call
Q2 disbursement target confirmed
Maintained₹1,200-1,250 Cr target MET with ₹1,205 Cr delivery (Sept quarter)
AUM growth guidance missed
DowngradePrior 13-14% vs actual 9-9.2% YoY at Sept; 4-5pp shortfall
Q3 and Q4 disbursement targets new
NewQ3: ₹1,300-1,350 Cr; Q4: ₹1,650-1,700 Cr; ambitious ramp required
NPA and profitability tracks maintained
MaintainedNPA: ₹427 Cr (June) → ₹398 Cr (Sept); FY27 profit: ₹480-490 Cr still intact
Cost of funds pressure accelerating
DowngradePost-RBI hikes, expecting +10-15 bps increase vs prior 8.3% stable guidance
The Q&A
Analysts pressed on AUM growth shortfall, technology/incentive confidence, and margin compression. Management held firm with specific explanations: DST/DSA channel ramp, LLMS systems stabilized, vertical org, branch expansion. Some skepticism on deputation change (Vaidyanathan → Kannan), but management said no impact. Analysts accepted answers but clearly testing confidence.
Disbursement guidance — Darshan Deora, Yes Securities
AnsweredQ3: ₹1,300-1,350 Cr; Q4: ₹1,650-1,700 Cr. Oct running on track with expectations. Sept achieved ₹1,205 Cr, hitting target.
NPA and credit costs — Darshan Deora, Yes Securities
AnsweredJune NPA ₹427 Cr brought down to ₹397-398 Cr. Expecting provision charge 5-6 Cr this quarter. Target: below 2% by year-end.
Growth confidence drivers — Abhijit Tibrewal, Motilal Oswal
PartialDST hiring, independent credit channel, sourcing improvements, LLMS stabilized, connector model. Salary costs up for staff and branch expansion, but sustainable.
Cost of funds and spread — Abhijit Tibrewal, Motilal Oswal
AnsweredCost of funds up 10-15 bps expected; 1-quarter lag to pass to borrowers. Spread 3.4% now, targeting 3.25-3.3%. Maintaining quality to retain customers.
Regional stress (South) — Vinod Vyas, Share India
AnsweredNo stress in South. Q1 Karnataka below normal; Q2 showing improvement. No regional deterioration.
Growth transformation — Harshit Toshniwal, Premji Investment
AnsweredSourcing team built, DSA/DST channels developed, processing improved, LLMS mobile app rolling, incentives revamped for sourcing. Systematic improvements, not one-time.
Asset quality at risk — Sanjana Sivaram, DAM Capital
AnsweredMajority loans urban/perimeter, Tier-1/2 cities. Portfolio assessment done; no drought stress. Cheque return ratios stable. Confident on 2% NPA target.
Dividend payout — Saikiran Pulavar, Individual
PartialInterim dividend ₹5 per share declared. No specific payout ratio in mind yet; final dividend based on FY27 profitability.
Guidance
FY27 profit ₹480-490 Cr (full year)
MediumH1 ₹230 Cr on track; implies H2 ₹250-260 Cr; depends on Q3-Q4 disbursement execution
NIM 5.44% at Sept; spread 3.4% maintained
MediumTargeting 3.25-3.3% spread going forward; cost of funds +10-15 bps pressure post-RBI hikes; will need discipline
Branch expansion 13-14 new branches FY27
HighPrimarily non-TN focus; majority non-TN; capital adequacy 37%, ample headroom
Risks the call surfaced
Cost of funds pressure
HighPost-RBI hikes, cost of funds expected to rise 10-15 bps from 8.35% current level. Lag of 1 quarter to pass to borrowers creates temporary margin compression.
AUM growth shortfall
HighAUM growth 9-9.2% YoY significantly misses prior 13-14% guidance. Indicates market demand, regulatory, or internal capacity constraints.
Margin compression
MediumSpread currently 3.4%, targeting 3.25-3.3% (10-15 bps compression). Combined with cost of funds increase, requires active pricing management.
Execution risk on disbursement ramp
MediumQ3-Q4 targets ambitious (₹1,300-1,350 Cr and ₹1,650-1,700 Cr). June quarter missed, requiring confidence in new channels.
NPA and asset quality deterioration
LowGross NPA 2.4%, target below 2% by year-end. While improving, any macro stress or disbursement quality compromise could reverse gains.
Management
Score 7/10. Specific on numbers; detailed on process improvements (DST, DSA, LLMS, vertical org). Transparent on challenges (cost pressure, AUM miss, margin compression). Some hedging on deputation change impact. Hit Q2 disbursement (₹1,205 Cr), but missed Q1 (₹843 vs ~₹1,000 Cr). Missed AUM growth (9.2% vs 13-14%). Delivered on NPA improvement (₹79 Cr YoY). Profitability on track (₹230 Cr H1).
1 · Q3 FY27 (Dec 2026)
₹1,300-1,350 Cr disbursement guidance; test of new DST/DSA channels
2 · Q4 FY27 (Mar 2027)
₹1,650-1,700 Cr disbursement guidance; aggressive 40%+ growth required
3 · FY27 close (Mar 2027)
Profit ₹480-490 Cr target; NPA below 2% target; dividend decision
Asset quality improving justifies the hold, but growth miss warrants caution.
Repco Home Finance Q2FY27: PAT up 8.6% YoY, but AUM growth of 9.2% trails 13-14% guidance
PAT +8.6% YoY · revenue +8.1% · margins flat
₹477.75 Cr
+8.1% YoY
₹119.09 Cr
+8.6% YoY
24.93%
+0.1pp YoY
₹19.04
Repco Home Finance's consolidated PAT rose 8.6% YoY to ₹119.09 Cr (₹109.66 Cr a year ago) on total income of ₹477.75 Cr, up 8.1% YoY — revenue and profit grew in step, with no exceptional items on either side of the comparison, so the reported and adjusted growth are the same. Sequentially, PAT slipped 2.1% QoQ from ₹121.62 Cr and the net profit margin eased to ~24.9% from 25.99% in Q1FY27, even though it is marginally better than the 24.82% margin a year ago — a modest QoQ softening rather than a YoY trend change, and one the limited newspaper-extract format (no interest-expense or spread breakup disclosed) doesn't let us attribute to a specific cost line. Standalone tracked consolidated closely (PAT ₹115.86 Cr, +8.3% YoY), so there is no material standalone-consolidated divergence to flag. Consolidated basic EPS was ₹19.04 versus ₹17.53 a year ago and ₹19.44 in Q1FY27.
Q2 FY-2027 vs prior quarters
Against management's own FY27 guidance from the Q1 concall — ₹5,000 Cr disbursements, 13-14% AUM growth, and a ₹40 Cr NPA reduction — this quarter is a mixed read. The company's own disclosure this week put loan book growth at 9.2% YoY to ₹16,425 Cr, running below the 13-14% AUM growth management had guided to, even as the P&L itself grew at a similar high-single-digit pace. Disbursement and NPA figures aren't broken out in this condensed extract, so those guidance checkpoints remain unverified pending the full results; management's cost-of-funds comfort (8.3%, aided by a ₹600 Cr NHB refinance line flagged last quarter) isn't testable here either given the margin line isn't disclosed. No analyst consensus or brokerage preview specifically for this Q2FY27 print turned up in a web search, so the result can't be benchmarked against the Street; broader FY27 PAT estimates (e.g., Motilal Oswal) were last revised up modestly off Q1 numbers, but that predates this print. No management press release was available to cross-check the company's own framing of the quarter.
The stock went into the print at ₹325.1, down 4.3% over the past month of trading.
For context: revenue is at a 6-quarter high.
FY2027 disbursement ₹5,000 Cr; AUM growth 13-14%; NPA reduction ₹40 Cr; Q2 target ₹1,200-1,250 Cr disbursements. Spread compression expected 10-12 bps; cost of funds stable at 8.3% aided by ₹600 Cr NHB refinance.
— This quarter: missed
The board that approved these results also considered an interim dividend (per the Nov 5 meeting notice), following a ₹3 final dividend declared in September and a board-approved increase in the borrowing limit to ₹20,000 Cr alongside plans to raise ₹1,500 Cr via NCDs and ₹1,000 Cr via CPs — all consistent with a lender scaling its balance sheet to fund growth. Two ESG upgrades (CRISIL, SES ESG at 71.70) and the appointment of joint statutory auditors for three years round out the quarter's non-P&L developments but don't bear directly on this print.
W1
AUM growth gap: 9.2% YoY loan book growth vs management's 13-14% FY27 guidance — watch if Q3 closes the gap toward the ₹5,000 Cr FY27 disbursement target
W2
NPA reduction target of ₹40 Cr flagged in the Q1 concall — not disclosed in this extract; check full results for asset-quality detail
W3
Margin trajectory: NPM eased to 24.9% from 25.99% QoQ — watch if the ₹600 Cr NHB refinance and 8.3% cost-of-funds guidance stabilize spreads next quarter
Newspaper-clipping extract (BSE Reg.33 format) discloses only Total Income from Operations with no other-income/expense split; totalExpenses and tax are derived as totalIncome−PBT and PBT−PAT. No exceptional/extraordinary items in either period — the 'before' and 'after exceptional items' PBT rows are identical for both the current and comparative columns.